Improving Functioning in Peripheral Arterial Disease
Cardiovascular Diseases, Peripheral Vascular Diseases
About this trial
This is an interventional treatment trial for Cardiovascular Diseases
Eligibility Criteria
Inclusion Criteria: 150 peripheral arterial disease patients with and without IC Exclusion Criteria: Below or above-knee amputation Wheelchair confinement Inability to walk on a treadmill or inability to perform progressive resistance training Inability to return to the medical center three times weekly for 6 months Walking impairment due to a cause other than PAD Class II New York Heart Association (NYHA) heart failure or angina (heart failure or angina occurring at rest or with minimal exertion) Planned lower extremity revascularization or any other major surgery within 12 months Any increase in anginal symptoms during the previous 6 months or angina at rest Subjects with silent coronary ischemia, defined as ST segment depression greater than or equal to 1 mm during baseline exercise treadmill test without associated chest discomfort, unless they have had a normal perfusion stress test during the previous 6 months Subjects with left-bundle branch block or significant ST-T wave changes on their baseline ECG who do not have a perfusion stress test demonstrating absence of reversible ischemia within the previous 6 months Lower extremity revascularization, major orthopedic surgery, or other major surgery during the previous 3 months Myocardial infarction or coronary artery bypass grafting during the previous 3 months Major medical illnesses that may interfere with subject's ability to complete the interventions and/or follow-up testing Current foot ulcer ABI greater than 0.95 Life expectancy less than 12 months Does not speak English Patient is currently involved in another clinical trial Dementia Poorly controlled blood pressure Current significant exercise, defined as exercising three times weekly for 30 minutes with sufficient exertion to produce a sweat or other exercise that is comparable to the exercise interventions offered in our protocol Treatment for cancer (other than non-melanoma skin cancer) during the past 12 months (including radiation therapy, chemotherapy, or surgery)
Sites / Locations
- Northwestern University Feinberg School of Medicine
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
1
2
3
6-month supervised treadmill exercise program
6-month supervised lower extremity progressive resistance training program
Diet/nutrition control group